CLINICAL EVALUATION OF KAKODUMBARADI GHANAVATI (IN- TERNAL) AND AYORAJADILEPA (EXTERNAL) IN THE MANAGE- MENT OF SWITRA (VITILIGO)

Similar documents
INTERNATIONAL JOURNAL OF AYURVEDA & ALTERNATIVE MEDICINE

Pharma Science Monitor 7(1), Jan-Mar 2016 PHARMA SCIENCE MONITOR

CLINICAL EVALUATION MIA

Research Article

EFFICACY OF SHIRISHA TWAK LEPA IN THE MANAGEMENT OF DADRU

Sk. Hafiz Hasan et al. Journal of Biological & Scientific Opinion Volume 6 (4). 2018

International Journal of Ayurvedic and Herbal Medicine 7:2(2017)

THE ROLE OF VIRECHANA KARMA WITH BAKUCHI CHURNA AND AV- ALGUJBEEJADI LEPA IN THE MANAGEMENT OF SHWITRA (VITILIGO)

A CLINICAL STUDY TO EVALUATE THE EFFICACY OF MANJISHTA LEPA AND MAHAMANJISHTADI KASHAYA IN THE MANAGEMENT OF YUVANA PIDAKA (ACNE VULGARIS) 1

Dr. K.L.A.P. SARMA MYTHILI G *

International Journal of Applied Ayurved Research ISSN: EFFICACY OF EKAVINSHATIKA GUGGULU IN THE MANAGEMENT OF VICHARCHIKA

Clinical Efficacy of Dhatryadi Ghanavati in Shvitra (Vitiligo)

World Journal of Pharmaceutical Research SJIF Impact Factor 7.523

A B S T R A C T INTRODUCTION OBJECTIVE OF THE STUDY. ISSN: ORIGINAL ARTICLE Mar-Apr Limbda, Vadodara.

International Journal of Applied Ayurved Research ISSN: SHODHANOTTARA SHAMANA CHIKITSA IN THE MANAGEMENT OF SHWITRA (VITILIGO)-A CASE REPORT

Vishwanath et al. Journal of Biological & Scientific Opinion Volume 3 (4). 2015

Evaluation of therapeutic efficacy of Surana Modaka in Arshas

ANVESHANA EFFECT OF ARAGVADHA PATRA KALKA AND ARNALA LEPA WITH AND WITHOUT CHAKRAMARDA SEED POWDER IN DADRU

(ISSN )

!!"# $%&'()*+,-./ %0405.6)*01)7*%()7,.8(91)7,

World Journal of Pharmaceutical and Life Sciences WJPLS

PDF of Trial CTRI Website URL -

International Journal of Ayurveda and Pharma Research

International Journal of Applied Ayurved Research ISSN: MANAGEMENT OF EKAKUSTHA (PSORIASIS) THROUGH AYURVEDA

THE PHARMA INNOVATION - JOURNAL Preparation of mulaka (Raphenus sativus linn.) Kshara - a practical approach

Greentree Group Publishers

CHAPTER VIII DISCUSSION

International Journal of Innovative Pharmaceutical Sciences and Research

World Journal of Pharmaceutical and Life Sciences WJPLS

Research Article International Ayurvedic Medical Journal ISSN:

AYURVEDIC MANAGEMENT OF DADRU KUSTHA VIS-À-VIS TINEA CORPORIS: A CASE STUDY

A CLINICAL STUDY TO EVALUATE THE EFFICACY OF AMALAKI CHURNA IN LEU- CORRHOEA

A clinical study on the role of herbal compound belfaladi churna in the management of atisaar

Int J Ayu Pharm Chem. e-issn

Therapeutic efficacy of Shirishavaleha prepared by Water and Kanji as liquid media and its effect on Tamaka Shwasa (Bronchial Asthma)

CLINICAL EFFICACY OF AMAVATARI RASA IN THE MANAGEMENT OF RHEUMATOID ARTHERITIS

AYUSHDHARA. An International Journal of Research in AYUSH and Allied Systems. Research Article

COMPARATIVE STUDY OF LEPROSY WITH SPECIAL REFERENCE TO AVASTHA IN KUSHTHA

International Journal of Applied Ayurved Research ISSN: A REVIEW ARTICLE-AYURVEDIC MANAGEMENT OF VICHARCHIKA (ECZEMA) THROUGH KANKARISTHA

International Journal of Applied Ayurved Research ISSN: ROLE OF VIRECHANA KARMA IN DADRU (TINEA CORPORIS) - A CLINICAL STUDY 1

International Journal of Applied Ayurved Research ISSN: ACTION OF AVIPATTI CHURNAM: AN AYURVEDIC PERSPECTIVE 1 Rajalekshmy.P.

IJMSS Vol.03 Issue-09 (September, 2015) ISSN: International Journal in Management and Social Science (Impact Factor- 4.

TO STUDY EFFICACY OF ARKA-TAILA IN MANAGEMENT OF VICHARCHIKA

VADI ASCHYOTANA (EYEE DROPS) IN THE TREATMENT OF COMPUTER VISION SYNDROME

Int J Ayu Pharm Chem. e-issn Sapna Chaudhary 1 *and Vinod Kumar Joshi 2 RESEARCH ARTICLE

Shodhana of Gandhaka (Sulphur) with Bhringaraj (Eclipta Alba) and Goghruta (Cow s Ghee)

A CLINICAL STUDY ON EFFICACY OF SHUKRAVARDHAKA DRAVYA ON SHUKRALPATA (OLIGOSPERMIA)

A Case Study of Agnikarma with Mrutika Shalaka in Pain Management of Calcaneal Spur Jayeshkumar Yadav 1 *, Raman R. Ghungralekar 2 and Geeta Varma 3

A COMPARATIVE STUDY OF RAKTASHODHAK GHANA VATI AND MUKHKANTIKARA LEPA WITH VAMAN KARMA IN THE MANAGEMENT OF YUVANPIDIKA ACNE VULGARIS

World Journal of Pharmaceutical and Life Sciences WJPLS

PRESENTING A WORK DONE BY Dr. DEVANGI PATEL IN THE YEAR 2004.

Key words: Shweta Pradara, Leucorrhea, Amalaki Choorna, Vata Twak Kashaya, Yoni Pichu.

STUDY THE EFFICACY OF KUMKUMADI GHRITA ABHYANGAA IN NILIKA Vd Chorghade Swati Anil 1 Dr. Rajendra S. Huparikar

A SUCCESSFUL MANAGEMENT OF BULLOUS PEMPHIGOID (VISPHOT) THROUGH AYURVEDA A CASE STUDY

International Journal of Innovative Pharmaceutical Sciences and Research

EVALUATION OF VIRECHANA KARMA AND SIRAVEDHA KARMA IN EK- KUSHTHA (PSORIASIS) A PILOT STUDY

To study the efficacy of brihatyadigana kwath in the management of mootrakrichhra w.s.r. to lower UTI

World Journal of Pharmaceutical and Life Sciences WJPLS

The role of Phalaghrita Uttarbasti in the management of Infertility w.s.r. Cervical Factor

International Journal of Ayurveda and Pharma Research

CLINICAL EFFICACY TWAKNAGAPUSHPADI CHURNA (PANA) IN MADATYAYA W.S.R. TO CHRONIC ALCOHOLISM

Clinical study of Palashadi Varti in the management of Pichchhila Yoni W.S.R. abnormal vaginal discharge

CLINICAL TRIALS OF VATSAKADI GHANAVATI AND MADHUTAILIK BASTI IN MADHUMEHA

A A M J Anveshana Ayurveda Medical Journal

ROLE OF RASA SINDHURA IN RESPIRATORY DISORDERS W.S.R TOTAMAKA SWASA

EFFICACY OF DHATRI AVALEHA IN PANDU (NUTRITIONAL ANAEMIA) AN OPEN END RANDOMIZED CLINICAL TRIAL

IMPROVEMENT OF MEDHA AN IMPERATIVE NEED OF THE ERA

Dr. Kruti Y Vyas [MD (AYU)]

ISSN International, Peer reviewed, Open access, Monthly Online Journal

Rashmi TM et al / Int. J. Res. Ayurveda Pharm. 5(6), Nov - Dec Research Article.

Vijakumar B et al / IJRAP 3(6), Nov Dec Research Article.

ANATOMICAL CHANGES OCCURING IN TWACHA SHARIR DUE TO DADRU W.S.R. TO RINGWORM

VITILIGO. Made by: Basma Noor, Maryam Mahjoub, Irin Chankao and Sara Samadi.

Management of Psoriasis (Kitibha-Kushtha) Through Classical Vamana Karma Followed by Internal Medicine : A Case Series

ISSN: PHARMACEUTICAL AND ANALYTICAL STANDARDIZATION OF RASAPACHAK VATI (TABLET)

A CONCEPTUAL ANALYSIS OF BHRAJAKA PITTA

SU M M A R Y. science often judged by the number of publications (Arunachalam S 2002). English

International Journal of Ayurveda and Pharma Research

ISSN: CLINICAL EVALUATION OF THE EFFICACY OF AN AYURVEDIC CREAM HEALMATE IN THE MANAGEMENT OF CRACKED HEELS (PAD-DARI)

Clinical Study on Evaluation of the Effect of Neem, Tulsi and Henna on Psoriasis

EVALUATION OF THE EFFICACY OF MUKHAKANTIKAR LEPA IN HYPERMELANOSIS WITH SPECIAL REFERENCE TO VYANGA

To Study the Effect of Jalaukavaacharan and Nimbatail in Comparison with Local Application of Nimbatail in Vicharchika w. r. t.

STUDY OF EFFECT OF YASHTIMADHU GHRITA AND MADHU LOCAL APPLICATION IN POST OPERATIVE PATIENTS OF HAEMORRHOIDECTOMY

Standardization of Nirgundi taila (oil) and its conversion into an ointment.

ROLE OF MADHUKADI TAILA KARNAPICHU AND RASNADI GUGGULU IN KARNASRAVA (CHRONIC SUPPURATIVE OTITIS MEDIA)

International Journal of Applied Ayurved Research ISSN: A CLINICAL STUDY TO EVALUATE THE EFFICACY OF MANJISHTHADI TAILA IN WOUND MANAGEMENT

A COMPARATIVE CLINICAL STUDY ON MITRAPANCHAKA YOGA AND AVALGUJABEEJADI LEPA IN THE MANAGEMENT OF SHWITRA W.S.R. TO VITILIGO

Asian Journal of Multidisciplinary Studies

School Of Ayurved, Navi Mumbai, Maharashtra, India. 2 Asso. Professor, Shalya Tantra Department, D. Y. Patil School Of Ayurved, Navi Mumbai,

A A M J Anveshana Ayurveda Medical Journal

EVALUATION OF EFFECT OF PUNARNAVA GHANVATI IN PRAMEHA UPDARVA WITH SPECIAL REFERANCE TO DIABETIC NEPHROPATHY

A A M J Anveshana Ayurveda Medical Journal

CLINICAL STUDY OF EFFICACY OF AROGYAVARDHINI VATI IN KAR- NASRAVA W.S.R. TO OTORRHOEA

EFFECT OF SHIREESH ON DOOSHHIVISHA

PHARMACO THERAPEUTIC EVALUATION OF PUTIKADI LEPA W. S. R. TO VITILIGO (SWITRA)

ROLE OF PRACHHAN KARMAA IN THE MANAGEMENT OF SHVITRA

REVIEW OF CLINICAL STUDIES CONDUCTED ON UPAPLUTA YONIVYAPAD (VULVOVAGINITIS DURING PREGNANCY) CONDUCTED AT IPGT & RA, JAMNAGAR

Physico-Chemical Study on Alambushadi Churna Tablet Saroj Kumar Debnath 1*, Sudhaben N. Vyas 2

Evaluation of Imuspora Tablets and Ointment (Multi-Ingredient Herbal Formulation) In the Management of Psoriasis: An Open Trial

ISSN International, Peer reviewed, Open access, Monthly Online Journal

Transcription:

Research Article International Ayurvedic Medical Journal ISSN:2320 5091 CLINICAL EVALUATION OF KAKODUMBARADI GHANAVATI (IN- TERNAL) AND AYORAJADILEPA (EXTERNAL) IN THE MANAGE- MENT OF SWITRA (VITILIGO) Attar Sajida Dilawar M.D. Scholar Kayachikitsa Dept. Y. M. T Ayurvedic College, P. G Institute & Hospital. Navi Mumbai, Maharashtra.India. ABSTRACT OBJECIVE: To evaluate the efficacy of Kakodumbaradi Ghanavati (internal) and Ayorajadilepa (ex- disorder involving mind and body, where in patient feels emotionally derangedd and it effects ternal) in the management of Switra. Switra (Vitiligo) is a hypopigmentation dermatological the appearance and outlook of the individual there by person immersed in deep agony, in short it induces social stigma. METHOD: The trial drug Kakodumbaradi Ghanavati internal and Ayorajadilepa external are considered for the evaluation in Switra.. The clinical study was undertaken on 30 patients in a single group. The hypothesis on the action of Ka- (anti- kodumbaradi Ghanavati (internal) has Kushtagna (curing skin diseases), krimighna helmintic), varnya (promote complexion), Switraghna prabhava along with deepana (digestive), pachana (digestion), Bruhana (nourishing), Balya (strengthening) and Vrushya (aph- potentially rodisiac) properties and Ayorajadilepa is verified its external action to introduce melanin pigmentation in this observational study. To assess the effect of treatment, color, number of mandalas (circular patches), VASI Score, hyper-pigmentation of, were considered. RESULTS: The results of the study are based upon the assessment of the subparameters are jective and objective criteria considered in the study. Mainly the objective considered to show the evidences of the relief in the study. The result encourages the Ayurbound study. vedic faternity even though the cure is only 6.67% (2 patients) in the time Study reveals well responded listed as 26.66% (8) patients along with the 37..66% of modmelanin repig- erately responded patients. In the study many causes made hindrances of the mentation and 8 i.e. 26.66% patients fall under poor response. Only one patient i.e. 3.34% noticed as the no response patient in the entire study. CONCLUSION: Subjective parameters viz. Rookshata (dryness), Parushataa (roughness), Daha (burning), Kandu (itching), Guruta (heaviness) are not significant in the study but all objective parameters are highly significant as per statistical evaluation. KEY WORDS: Ayorajadilepa, hypopigmentation, Kakodumbaradi Ghanavati, shwitra, viti- ligo, VASI Score INTRODUCTION Switra is a dermatological disorder having its references cited in the Vedas (science). The term is combination of Swith and Rik 1. Swith means whiteness and Rik is suffix of Shweta Dhatu. Shabda- kalpadruma defined the term for white colored object 2. The Nirukti of the term retoward white veals white color or changes color. Switra is a disease pertaining to Twak (skin) which turns the normal colour of the skin to white. The cardinal symp- of toms of Switra are the appearance Apa-

risravi shweta varna mandalas, on the skin that is depigmented patches or macules. These patches are more common in sun-exposed areas including the hands, feet, arms, face and lips. 4 The change in appearance caused by this condition can affect a person s emotional and psychological well being. Switra inflates an inferiority complex in the persons affected. Switra emerges as a sequel to irregular dietary habits, life style changes, and genetic predisposition. Worldwide prevalence of Vitiligo is observed as 1% of the world population. 5 This condition affects about 1-2% of the world s population and 3-4% in India. All the races and both sexes are equally affected. Based on the clinical features of Switra, it can be correlated to vitiligo of the modern medicine. Vitiligo on the face is ranked 17th by WHO in world s most disabling diseases. It is defined as a common acquired discoloration of the skin characterized by well circumscribed ivory or chalky white macules which are flush on to the surface. 6. The hair over the patch may be white or normal. Vitiligo is a localized type of hypopigmentation disorder where single or multiple patches of hypopigmented area are seen. Either it might be symmetrical or nonsymmetrical. Of the various treatment approaches offered by conventional medicine, from the good old PUVA therapy, to using corticosteroids, to epidermal grafts or cell culture techniques none is completely effective in all presentation of Vitiligo. Further some of conventional approaches have unacceptable side effects or either unaffordable or not easily accessible in all parts of the country. Ayurvedic treatment in this concern through holistic approach, can improves the patient s appearance and restore the normal pigmentation of the skin. Since Vitiligo affects irrespective of poor and rich and as well as children and adults, a clinical study was planned to access the efficacy of an indigenous preparations based on the Ayurvedic principles. Thus the Kakodumbaradi Ghanavati and Ayorajadilepa mentioned in Sahasrayoga and Yogaratnakara are selected for internal and external application respectively, as the contents of these drugs are easily available, economic and good result oriented. So the present study Evaluation of the efficacy of Kakodumbaradi ghanvati and Ayorajadi lepa are undertaken, which are with Switraghna and Varnaya properties. MATERIAL AND METHODS The methods adopted in the study are discussed as under. PLAN OF STUDY An open label clinical trial was conducted, where the patients were given treatment with specific duration with every 5 days follow up. Oral corticosteroids were withdrawn at least 4 weeks before commencement of trial. Specific instructions on diet and life style modifications were advised to the patients. Institutional Ethics Committee (IEC) approval was obtained and written consent was taken from the patients prior to the initiation of the study. SOURCE OF DATA:- a) Patients suffering from Switra are selected from. Dept of Kayachikitsa OPD of Y.M.T Ayurvedic Medical College and Hospital by Preset Inclusion and exclusion criteria. b) Literary: - Literary aspects of study are collected from classical Ayurvedic and contemporary texts and updated with recent Medical Journals. DIAGNOSTIC CRITERIA: Shweta varna mandalas with or without other features of switra INCLUSION CRITERIA:- 1. Patients with classical symptoms of Switra as explained in Ayurvedic classics and diagnosed case of Vitiligo according to the contemporary diagnostic system are included EXCLUSION CRITERIA:- 737

1. Patients below 10 years irrespective of sex are excluded. 2. Patients above 60 years of age, irrespec tive of sex are excluded 3. Pregnant women and lactating women are excluded. 4. Patients suffering from other systemic disease are excluded. 5. Patients with Burnt areas are excluded. 6. The patches over lips and mouth angula tions are excluded. 7. The genital area patches are excluded. DRUG REVIEW In the present study the drug for study is - Kakodumbaradi Ghanavati internally and Ayorajadilepa externally possess the following proportions in it. 1) The combination and proportion of Kakodumbaradi Ghanavati is as follows.table NO 1 2) The combination and proportion of Ayorajadilepa is as followstable 2 All the drugs are well identified and collected from local areas. Good manufacturing practice are followed for the preparation of Yogas. The Kakodumbaradi kwatha which is mentioned in kwatha kalpana is taken in the form of Ghanavati because of its palatability form. POSOLOGY Administration of Drug: Internally Kakodumbaradi Ghanavati 2 tabs of 500 mg thrice daily after the food with water Externally Ayorajadi lepa Q.S. rubbed in water to paste and applied all over the effected skin for 30 minutes exposed in the sun light. Follow up: 15 days ASSESSMENT OF RESULT Subjective and objective parameters will be assessed for result. I) SUBJECTIVE PARAMETER: Signs and symptoms as designed in classical texts 1. Rukshata: becoming skin dryness at depigmented surface is identified as different Grade 0 Normal skin dryness 2. Parushata: becoming skin roughness at depigmented surface is identified as different Grade 0 Normal skin roughness 3. Paridwamshi: getting dusty skin at depigmented surface is identified as different Grade 0 Normal dusty skin 4. Daha: getting burning sensation of skin at depigmented surface is identified as different Grade 0 No Burning sensation 5. Roma Patana: getting hair falling at depigmented surface is identified as different Grade 0 No hair fall 6. Kandu: getting itching at depigmented surface is identified as different grades are as follows Grade 0 No itching 7. Kleda: getting moisture skin at depigmented surface is identified as different Grade 0 Normal skin 738

8. Srava: getting discharge at depigmented surface is identified as different grades are as follows Grade 0 Normal skin II) OBJECTIVE PARAMETER For the assessment of results the following objective parameter were consider i) Colour ii) Margin iii) Number iv) VASI score. To assess the effect number and VASI score were consider as they are without grading before and after treatment. To assess the improvement in colour and the following grading were given. 1. Colour: The colour of your skin is due to an interaction between (1) Pigment composition and concentration and (2) The dermal blood supply. The Grade 0 Normal skin colour Grade 1 Non-unified normal skin Grade 2 Pigmentation is more than depigmentation Grade 3 Depigmentation equal or more than pigmentation Grade 4 Depigmentation more than pigmentation Grade 5 Complete Depigmentation 2. Margin: s of the lesions are enumerated as grades are as follows. Grade 0 Normal skin colour attributed Grade 1 Hyper pigmented thick broad width graduated Grade 2 Hyper pigmented broad width graduated Grade 3 Hyper pigmented well defined 739 Grade 4 Hyper pigmented thin edge Grade 5 Ill defined 3. VASI score: 16 VASI is to divide the patient into various body regions such as the arms, trunk, legs, hands and feet. Then using the assumption that a palm of the hand is equivalent to 1% of the body surface, the physician determines how much of the skin is affected by Vitiligo. Then the physician determines what percent of the skin is depigmented by referring back to standardized pictures of various degree of pigmentation VASI = Sum of value of product of palm units X Extent of depigmentation Total Body surface area II) OVERALL ASSESSMENT Overall assessment of the results are done considering the cumulative effect of subjective and objective parameters. The disease is not totally manageable within the scheduled time, the grades of assessment of results made as under. TABLE NO. 3 OBSERVATION: The major improvement was observed in colour and of the mandala. The cure rate was observed 6.66% in all the parameter. Well response was found in 33.33% of patients in the colour, 46.66% in the, 26.66% VASI score and 0% in the number of mandala. Moderate response was noticed in 36.66% of the patients in the colour.16.66% in the and 36.66% in the number and 23.33% in VASI score of mandala. Poor response was observed in 16.66% in the colour, 26.66% in both and number and 40% of patients in VASI score of the mandal RESULTS Assessment of subjective parameters in Switra TABLE NO 4

Assessment of Objective parameters in Switra TABLE NO.5 The subjective parameters which are considered here show marked response with good percentage of relief. At the objective parameters all has shown the variances on the positive declination in the study. Results in Switra with Kakodumbaradi Ghanavati and Ayorajadilepa TABLE 6 Statistical analysis of the clinical and objective parameters Subjective parameter Statistical analysis in Switra with Kakodumbaradi Ghanavati and Ayorajadilepa TABLE NO. 7 Objective parameter Statistical analysis in Switra with Kakodumbaradi Ghanavati and Ayorajadilepa TABLE NO. 8 DISCUSSION The ingredients of Kakodumbaradi Ghanavati act over tridoshas (disorders of the 3 humours) and pacify them. Kakodumbara: By its tikta (bitter), kashaya (astringent) rasa acts as kapha-pitta shamaka (kapha pitta pacifier), kushtaghna and kandughna. Vidanga: By its ushna veerya warm potency) acts as vata shamaka. By katu (pungent) rasa and katu vipaka acts as kapha shamaka, and srotoshodhaka (channel purifier). Bakuchi: By its katu, tikta rasa, laghu-rooksha guna, and ushna veerya acts as srotoshodhaka, kapha-pitta shamaka and krimighna. Ayourajadi lepa having ushana,teekshana and srotoshodaka properties the veerya of lepa reaches the siramuka of swedava srotas and reach the deeper layer twak and it act locally to relive the sanga. By this the samapurana of Bhrajaka pitta takes place and hencenormal function is noticed. CONCLUSION 740 1. Some physician emphasizes the topical treatment, others emphasize the internal treatment, but both appear important to the prompt and complete resolution of Switra. 2. The complete cure was observed, 6.66% i.e.2 patients, who are having small lesion and recent onset. The remaining patients were also relieved moderately, from their symptoms. 3. Clinical and statistical analysis reveals that the systemic corrections can be done with internal preparation and the local stimulation by synthesis of melanin through external application may be effective in the management of Switra vis-à-vis Vitiligo. 4. Finally it can be very safely concluded that the above mentioned drug combination has positive role in the management of Switra. REFERENCES 1. Ambikadatta Shastri, Susruta Samhita, Nidanastana,5th chapter,17th sloka, 15th ed, Varanasi,Chokamba Sanskrit samstana ;2002, page no 29. 2. Radhakanta deva,shabdakalpa Dhruma,5th part, 3rd ed, Varanasi, Chokamba Sanskrit samstana,,1967 page no 180. 3. Ambikadatta Shastri,Susruta Samhita,Nidanastana,5th chapter,17th sloka, 15thVaranasi, Chokamba Sanskrit samstana; 2002, page no 249. 4. Viswanath Jha, Amarakosha, 2nd ed, Pune, Motilal Bamarasidar; page no 283. 5. John A.A.Hunter ed, Davidson s principles and practice of medicine, 21st chapter, 19th ed, Churchill Livingstone; 2002. pg 1086, 1087. 6. Antony S. Fauci, Dennis L.Kasper ed Harrison s Principles of internal medicine part2 chapter 54, Mc Graw Hill

Medical publication; 17nth edition, pg. 324. 7. K.M Nadakarni, Indian Materia Medica, Vol I, 3rd ed, Bombay, popular prakashan; 1996, Page 550. 8. K.M Nadakarni, Indian Materia Medica, Vol I, 3rd ed, Bombay,popular prakashan; 1996, Page 478 9. K.M Nadakarni, Indian Materia Medica, Vol I, 3rd ed, Bombay, popular 10. K.M Nadakarni, Indian Materia Me dica, Vol II, 3rd ed, Bom bay,popular prakashan; 1996, Page 54. 11. K.M Nadakarni, Indian Materia Medica, Vol I, 3rd ed,bombay, Popular prakashan;1996, Page 112 12. K.M Nadakarni, Indian Materia Medica, Vol I, 3rd ed,bombay, popular prakashan; 1996, Page 187. TABLE NO.1 13. K.M Nadakarni. Indian Materia Medica, Vol I,,. 3rd ed. Bombay. popular prakashan, ; 1996, Page 480. 14. K.M Nadakarni. Indian Mate ria Medica, Vol I,,. 3rd ed. Bombay. popular prakashan, ; 1996, Page 169 15. Dr. J L N Shastry,Drayaguna Vijnana, vol II, 1st ed, Varana si, Choukhambha Orientalia, 2004,page no184-186. 16. Dr Harvey Lui. Reference: Hamzavi I, Jain H, McLean D, Shapiro J, Zeng H, Lui HParametric Modeling of Narrow Band UVB Phototherapy for Vitiligo with a Novel Quantitative Tool: the VASI Score Archives of Dermatology June: 140; 677-683, Update on Clinical research for Vitiligo: The VASI score, By Iltefat Hamzavi, MD,Clinical Assistant Professor, Department of Dermatology, Wayne State University Sr.No Drug & Botanical Name Proportion 1 KAKODUMBAR TWAK (Ficus hispida) 7 One part 2 VIDANGA (Emblia ribes) 8 One part 3 BAKUCHI BEEJA (Psoralia corylifolia) 9 One part TABLE NO. 2 Sr.NO Drug & Botanical Name Proportion 1 AYORAJA (Ferrum) 10 One part 2 KRISHNATILA (Sesamum indicum) 11 One part 3 RASANJANA (beriberi extract) 12 One part 4 BAKUCHI BEEJA (Psoralia corylifolia) 13 One part 5 AMALAKI (Emblica officinalis) 14 One part 741

6 BHRINGARAJA (Eclipta alba) 15 One part TABLE NO.3 ASSESSMENT COLOR MARGIN NUMBER IN VASI SCORE % Cured Normal Normal or no 100 0 Well responded non unified normal skin colour Moderately Responded: pigmentation equal to depigmentation hyper pigmented thick broad width graduated hyper pigmented broad width graduated more than 75% more than 50% more than 75% more than 50% Poorly Responded: Not responded depigmentation is more than pigmentation No pigmentation developed hyper pigmented well defined No changes in less than 50% No less than 50% No TABLE NO.4 Subjective parameters Patients Before Patients After Patients Changed Changed % Rookshata 5 1 4 80 Parusha 2 1 1 50 Daha 2 1 1 50 Kandu 4 2 2 50 Guruta 1 0 1 100 TABLE NO.5 Objective parameters Mean Before Mean After Mean Difference Colour 4.06 1.866 2.0194 Margin 4.133 1.866 2.266 Number 13.76 9.76 3.99 742

VASI 1.174 0.579 0.595 TABLE NO.6 Result Number of patients Percentage Cured 2 6.67 Well Responded 8 26.66 Moderately Responded 11 36.67 Poor Responded 8 26.66 Not Responded 1 3.34 Total 30 100 TABLE NO. 7 Subjective Mean SD SE t-value p-value parameters significance Rookshata 0.266 0.52 0.095 2.804 >0.05 NS Parusha 0.066 0.365 0.066 1.0 >0.05 NS Daha 0.1 0.402 0.073 1.36 >0.05 NS Kandu 0.3 0.65 0.118 2.523 >0.05 NS Guruta 0.13 0.434 0.079 1.68 >0.05 NS HS = Highly Significant, ID = Insufficient Data TABLE NO.8 Objective parameters Mean SD SE t-value p-value Significance Colour 2.2 0.961 0.175 12.53 <0.001 HS Margin 2.26 1.04 0.191 11.84 <0.001 HS Number 4.06 5.686 1.03 3.94 <0.001 HS VASI 0.296 0.435 0.079 3.72 <0.001 HS HS = Highly Significant CORRESPONDING AUTHOR Vd. Attar Sajida dilawar M.D. Scholar Kayachikitsa Dept. Y. M. T Ayurvedic College, P. G Institute & Hospital. Navi Mumbai, Maharashtra,India. Email:dr.sajidaattar@yahoo.com 743